title: Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development.
authors.affiliation: Metabolomics & Enzymology Unit, Fundamental and Applied Biology Group, King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia. prof.makamal@lycos.com.
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Kamal
authors.affiliation: Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National, Institute on Aging, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA. greign@grc.nia.nih.gov.
authors.forename: Nigel H
authors.initials: NH
authors.lastname: Greig
mesh_terms: D019468:Disease Management; D055808:Drug Discovery; D006801:Humans; D057170:Translational Research, Biomedical
references.citation: Curr Pharm Des. 2016;22(5):527-34
references.pmid: 26601962
references.citation: Curr Pharm Des. 2016;22(5):566-71
references.pmid: 26601967
references.citation: Curr Pharm Des. 2016;22(5):549-65
references.pmid: 26601968
references.citation: Curr Pharm Des. 2016;22(5):582-9
references.pmid: 26601961
references.citation: Curr Pharm Des. 2016;22(5):572-81
references.pmid: 26601966
references.citation: Curr Pharm Des. 2016;22(5):535-40
references.pmid: 26601969
references.citation: Curr Pharm Des. 2016;22(5):518-26
references.pmid: 26601970
references.citation: Curr Pharm Des. 2016;22(5):595-608
references.pmid: 26601964
references.citation: Curr Pharm Des. 2016;22(5):541-8
references.pmid: 26601965
references.citation: Curr Pharm Des. 2016;22(5):590-4
references.pmid: 26601963